X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (446) 446
male (320) 320
tropanes - therapeutic use (291) 291
female (261) 261
middle aged (187) 187
adult (174) 174
index medicus (164) 164
animals (134) 134
pharmacology & pharmacy (123) 123
aged (116) 116
tropanes - pharmacology (104) 104
tropanes (89) 89
tropanes - administration & dosage (68) 68
parasympatholytics - therapeutic use (67) 67
tropanes - adverse effects (62) 62
pulmonary disease, chronic obstructive - drug therapy (61) 61
neurosciences (59) 59
adolescent (56) 56
clinical neurology (56) 56
psychiatry (55) 55
tomography, emission-computed, single-photon (54) 54
benztropine - therapeutic use (53) 53
dopamine transporter (50) 50
dopamine plasma membrane transport proteins - metabolism (49) 49
bronchodilator agents - therapeutic use (48) 48
dose-response relationship, drug (48) 48
drug therapy, combination (48) 48
rats (48) 48
time factors (44) 44
clinical trials as topic (42) 42
treatment outcome (40) 40
radiopharmaceuticals (38) 38
muscarinic antagonists - therapeutic use (36) 36
double-blind method (35) 35
respiratory system (35) 35
tropanes - pharmacokinetics (35) 35
parkinson's disease (34) 34
spect (34) 34
levodopa - therapeutic use (33) 33
pulmonary disease, chronic obstructive - physiopathology (32) 32
tropane alkaloids (32) 32
tiotropium (31) 31
tomography, emission-computed, single-photon - methods (31) 31
brain - diagnostic imaging (30) 30
drug combinations (30) 30
mice (30) 30
parkinson disease - diagnostic imaging (30) 30
parkinson disease - drug therapy (30) 30
dopamine (29) 29
atropine - therapeutic use (28) 28
child (28) 28
schizophrenia - drug therapy (28) 28
tropanes - metabolism (28) 28
antiparkinson agents - therapeutic use (27) 27
corpus striatum - diagnostic imaging (27) 27
aclidinium bromide (26) 26
administration, inhalation (26) 26
efficacy (26) 26
brain - metabolism (25) 25
chemistry, medicinal (25) 25
guinea pigs (25) 25
obstructive pulmonary-disease (25) 25
safety (25) 25
serotonin antagonists - pharmacology (25) 25
chronic obstructive pulmonary disease (24) 24
binding (23) 23
bronchodilator agents - administration & dosage (23) 23
severity of illness index (23) 23
copd (22) 22
dopamine plasma membrane transport proteins (22) 22
lung diseases, obstructive (22) 22
brain (21) 21
in vitro techniques (21) 21
muscarinic antagonists - administration & dosage (21) 21
muscarinic antagonists - adverse effects (21) 21
pharmacokinetics (21) 21
research (21) 21
tropanes - chemistry (21) 21
aged, 80 and over (20) 20
bronchodilator agents - adverse effects (20) 20
toxicology (20) 20
aclidinium (19) 19
alkaloids (19) 19
corpus striatum - metabolism (19) 19
drug therapy (19) 19
benztropine - adverse effects (18) 18
biochemistry & molecular biology (18) 18
brain - drug effects (18) 18
care and treatment (18) 18
iodine radioisotopes (18) 18
basal ganglia diseases - chemically induced (17) 17
basal ganglia diseases - drug therapy (17) 17
dopamine - metabolism (17) 17
parkinson disease - metabolism (17) 17
scopolamine (17) 17
analysis (16) 16
asthma - drug therapy (16) 16
chronic disease (16) 16
cocaine (16) 16
diagnosis, differential (16) 16
more...
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (485) 485
German (27) 27
French (23) 23
Russian (14) 14
Italian (12) 12
Polish (11) 11
Dutch (6) 6
Japanese (6) 6
Spanish (4) 4
Czech (2) 2
Serbian (2) 2
Ukrainian (2) 2
Danish (1) 1
Finnish (1) 1
Hebrew (1) 1
Norwegian (1) 1
Portuguese (1) 1
Slovak (1) 1
Swedish (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Current Opinion in Pulmonary Medicine, ISSN 1070-5287, 03/2018, Volume 24, Issue 2, pp. 130 - 137
PURPOSE OF REVIEWRecent updates to the GOLD guidelines emphasize the use of combination LABA and LAMA bronchodilators for patients with chronic obstructive... 
Long-Acting muscarinic antagonists | Chronic obstructive pulmonary disease | Long-Acting beta agonists | Bronchodilator | CO-SUSPENSION(TM) DELIVERY TECHNOLOGY | long-acting beta agonists | LUNG-FUNCTION | FLUTICASONE PROPIONATE/SALMETEROL | SALMETEROL-FLUTICASONE | ONCE-DAILY TIOTROPIUM | ACLIDINIUM BROMIDE | TO-SEVERE COPD | RESPIRATORY SYSTEM | LONG-TERM SAFETY | PARALLEL-GROUP | DOUBLE-BLIND | bronchodilator | chronic obstructive pulmonary disease | long-acting muscarinic antagonists | Bronchodilator Agents - therapeutic use | Bronchodilator Agents - administration & dosage | Humans | Muscarinic Antagonists - therapeutic use | Benzyl Alcohols - therapeutic use | Indans - therapeutic use | Quinuclidines - therapeutic use | Tiotropium Bromide - administration & dosage | Quinolones - therapeutic use | Tiotropium Bromide - therapeutic use | Indans - administration & dosage | Formoterol Fumarate - therapeutic use | Benzoxazines - administration & dosage | Glycopyrrolate - therapeutic use | Administration, Inhalation | Tropanes - therapeutic use | Benzoxazines - therapeutic use | Muscarinic Antagonists - administration & dosage | Quinolones - administration & dosage | Glycopyrrolate - administration & dosage | Chlorobenzenes - therapeutic use | Delayed-Action Preparations | Drug Combinations | Practice Guidelines as Topic | Pulmonary Disease, Chronic Obstructive - drug therapy | Lung diseases, Obstructive | Dosage and administration | Safety and security measures | Research | Drug therapy | Bronchodilator agents
Journal Article
Journal Article
European Neuropsychopharmacology, ISSN 0924-977X, 2013, Volume 24, Issue 1, pp. 160 - 171
Journal Article
COPD: Journal of Chronic Obstructive Pulmonary Disease, ISSN 1541-2555, 8/2013, Volume 10, Issue 4, pp. 511 - 522
Journal Article